Argenx is a hold due to limited catalysts in 2025, a rich valuation and clinical risk around label expansion. Read more about ...

Rheumatologists and cardiologists have long co-managed patients out of necessity and without much formal collaboration or ...

Although I have been a patient in rheumatology since I was 3, I didn't get “hooked on rheum” until I took a leave of absence ...

Iron-dependent ferroptosis, a non-apoptotic cell death mechanism, is gaining attention for its role in immune suppression.

Widespread chronic pain in patients with hypermobility spectrum disorder or hypermobile Ehlers-Danlos syndrome significantly affected daily activities.

Belimumab plus standard therapy effectively improves mucocutaneous SLE symptoms compared with placebo plus standard therapy, especially in patients with high disease activity and serological activity.